# Reducing anxiety and depression in Chinese adolescents through group behavioral activation: a pilot study with school-based implementation

**Authors:** Fang Zhang, Wenjing Liu, Hongmei Yang, Yang Sun, Xiaoxia Lei, Yue Ding, Xiaochen Zhang, Zhishan Hu, Shuaishuai Hu, Zhen Wang, Wenhong Cheng

PMC · DOI: 10.1186/s13034-025-01012-1 · 2025-12-24

## TL;DR

A school-based therapy called GBAT reduced anxiety and depression in Chinese teens, with effects lasting three months.

## Contribution

This study demonstrates the effectiveness of implementing GBAT in schools for adolescent mental health.

## Key findings

- GBAT significantly reduced anxiety symptoms in adolescents immediately after the intervention.
- Improvements in anxiety and depression were maintained at the 3-month follow-up.
- GBAT showed moderate to large effect sizes in reducing mental health symptoms.

## Abstract

Anxiety and depression are increasingly prevalent public health concerns among adolescents. Group Behavioral Activation Therapy (GBAT), a structured school-based intervention, has shown promise as a potential approach for alleviating these conditions.

This quasi-experimental trial evaluated the efficacy of school-implemented GBAT in reducing anxiety and depressive symptoms among Chinese adolescents. Participants (N = 139; aged 12–17 years; 44.6% male) were assigned to either a GBAT group (n = 72) or a waitlist control group (n = 67). The GBAT protocol consisted of eight weekly 90-minute sessions. Outcomes were assessed at baseline, post-intervention, and 3-month follow-up using the Screen for Child Anxiety Related Emotional Disorders (SCARED) and the Depression Self-Rating Scale for Children (DSRSC).

A total of 93.06% of students completed all eight GBAT sessions. Post-intervention SCARED scores decreased significantly, t (135) = 2.44, MD = 4.20, 95% CI [0.79, 7.60], p = 0.016, Cohen’s d = 0.42. Linear mixed-model analysis revealed a significant group effect (F (1,397) = 10.60, p = 0.001), indicating lower anxiety scores in the GBAT group compared with the waitlist control. A significant time effect was also observed, F (1,397) = 7.64, p < 0.001. At 3-month follow-up, GBAT maintained significant improvement in anxiety (SCARED: MD = 8.69, 95% CI [3.58, 13.80], p < 0.001 Cohen’s d = 0.82) and depressive symptoms (DSRSC: MD = 2.28, 95% CI [0.10, 4.46], p = 0.037, Cohen’s d = 0.43), indicating moderate to large effect sizes.

These preliminary findings suggest that GBAT may be a promising primary prevention strategy for adolescent mental health. This study provides a foundation for future research exploring its potential integration into school-based mental health frameworks.

## Linked entities

- **Diseases:** anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Diseases:** Depression (MESH:D003866), Anxiety (MESH:D001007), Anxiety Related Emotional Disorders (MESH:D001008)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12859829/full.md

---
Source: https://tomesphere.com/paper/PMC12859829